Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Providence Therapeutics Inc.

Headquarters: Calgary, Canada
Year Founded: 2015
Status: Private

BioCentury | Feb 3, 2023
Management Tracks

Vessey to leave BMS in July

Plus: Nichols joining enGene as CEO and updates from Invivyd, Exai and more
BioCentury | Nov 2, 2022
Management Tracks

Cox to head digital health at Pfizer

Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more
BioCentury | Sep 14, 2021
Finance

Remembering Fred Frank, Lisa Raines, plus CRISPR, Washington updates

Deal in Focus: An mRNA partnership between Chinese in-licensing play Everest Medicines and Canadian biotech Providence Therapeutics
BioCentury | Sep 14, 2021
Deals

Everest parlays Blanchard’s network into mRNA vaccine

Two deals on the week bring in-licensed clinical assets to 10
Items per page:
1 - 4 of 4